A kind of preparation method of gastric floating hollow sustained-release tablet
A sustained-release tablet and gastric floating technology, which is applied in the direction of making medicines into special physical or ingestible devices, pill delivery, active ingredients of heterocyclic compounds, etc., can solve the problem of complex manufacturing process, easy damage, and easy breakage and other problems, to achieve the effect of simple manufacturing process, prolonging the integrity time, and maintaining continuous floating
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0037] a. Preparation of plain tablets: Weigh the main drug and various pharmaceutical excipients in the prescribed amount, mix them evenly, pass through a No. 5 sieve (180 μm ± 7.6 μm), and use a tableting mold to compress out a concave surface in the middle and a peripheral edge. Planar tablets, such as Figure 1a shown, spare;
[0038] b, the preparation of coating solution: take the tablet coating material of prescribed quantity, plasticizer and anti-tack agent and dissolve in solvent, fully stir, filter with No. 3 sieve (355 μm ± 13 μm), obtain coating solution for subsequent use If the prescription of the coating solution includes an antifoaming agent, then add the antifoaming agent after the above-mentioned stirring, then stir for 30min, and finally filter with a No. 3 sieve (355 μm ± 13 μm) to obtain the coating solution for subsequent use;
[0039] c. Preparation of tablet unit: Use the above-mentioned coating solution to evenly spray the concave surface and its perip...
Embodiment 1
[0058] Example 1: Diltiazem hydrochloride gastric floating hollow sustained-release tablet
[0059] (1) Prescription composition
[0060] A, plain tablet prescription:
[0061] Component name Dosage (1000 tablets)
[0062] Main medicine:
[0063] Diltiazem Hydrochloride 100g
[0064] medical supplements:
[0065]
[0066] B, coating liquid prescription:
[0067]
[0068]
[0069] (2) Determination of cumulative release
[0070] According to ultraviolet spectrophotometry, the absorbance was measured at the wavelength of 236nm, and the cumulative release was calculated. The results are as follows figure 2 shown.
Embodiment 2
[0071] Example 2: Norfloxacin gastric floating hollow sustained-release tablet
[0072] (1) Prescription composition
[0073] A, plain tablet prescription:
[0074] Component name Dosage (1000 tablets)
[0075] main medicine
[0076] Norfloxacin 200g
[0077] medical supplements:
[0078]
[0079] B, coating liquid prescription:
[0080]
[0081] (2) Determination of cumulative release
[0082] According to ultraviolet spectrophotometry, the absorbance was measured at the wavelength of 278nm, and the cumulative release was calculated. The results are as follows image 3 shown.
PUM
| Property | Measurement | Unit |
|---|---|---|
| diameter | aaaaa | aaaaa |
| diameter | aaaaa | aaaaa |
| diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


